Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-02-21FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Buspirone Hydrochloride by Aurobindo Pharma Limited, authorizing continued manufacture and suppl…
-
FDA approval · 2020-02-04FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Radha Pharmaceuticals, Inc.)
The FDA approved a supplemental application for buspirone hydrochloride submitted by Radha Pharmaceuticals, Inc., under an approved ANDA.
-
FDA approval · 2019-12-31FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Alprazolam from Sandoz Inc, confirming approval of a generic Alprazolam product.
-
FDA approval · 2019-12-31FDA Approved: ALPRAZOLAM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Alprazolam from Aurobindo Pharma Limited.
-
FDA approval · 2019-12-31FDA Approved: ALPRAZOLAM — Supplemental Application (Actavis Pharma, Inc.)
FDA approves Actavis Pharma, Inc.'s supplemental application for a generic alprazolam product, confirming approval of the supplemental submi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-12-13FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental abbreviated new drug application for duloxetine hydrochloride from Aurobindo Pharma Limited (ANDA 090778), e…
-
FDA approval · 2019-11-14FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved buspirone hydrochloride from Unichem Pharmaceuticals (USA), Inc. under an Original Application for the treatment of generalized…
-
FDA approval · 2019-10-31FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Chartwell RX, LLC)
FDA approved Venlafaxine hydrochloride (extended-release) from Chartwell RX, LLC under an Original Application (ANDA).
-
FDA approval · 2019-09-11FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA supplemental approval granted for Apotex Corp's paroxetine hydrochloride product, approving a generic formulation under NDA 020936.
-
FDA approval · 2019-08-29FDA Approved: VENLAFAXINE — Original Application (Modavar Pharmaceuticals LLC)
FDA approved a generic venlafaxine product from Modavar Pharmaceuticals LLC via an Original Abbreviated New Drug Application (ANDA). The gen…
-
FDA approval · 2019-08-16FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Yaopharma Co., Ltd.)
FDA approved the original application for duloxetine hydrochloride from Yaopharma Co., Ltd., granting approval for the generic product to be…
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Cipla USA, Inc.)
FDA approves Cipla USA, Inc.'s original application for pregabalin, granting a generic version of the drug for its established indications.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' generic pregabalin under ANDA207623 (original application), providing a generic version of pregabalin.
-
FDA approval · 2019-05-22FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approves a supplemental application for a generic duloxetine from Zydus Lifesciences Limited, authorizing marketing of the product.
-
FDA approval · 2019-04-17FDA Approved: DULOXETINE — Original Application (Qingdao BAHEAL Pharmaceutical Co., Ltd.)
FDA approved a generic version of duloxetine from Qingdao BAHEAL Pharmaceutical Co., Ltd. under an Original Application (ANDA 210599). The a…
-
FDA approval · 2019-04-16FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Radha Pharmaceuticals, Inc.)
FDA approves a supplemental application for buspirone hydrochloride from Radha Pharmaceuticals, Inc., granting regulatory approval for this …
-
FDA approval · 2019-04-16FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (Epic Pharma, LLC)
The FDA approved an Original Application for Buspirone Hydrochloride from Epic Pharma, LLC, enabling a generic version of the anxiolytic for…
-
FDA approval · 2019-03-29FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Venlafaxine Hydrochloride from Sun Pharmaceutical Industries to support the generic product's co…
-
FDA approval · 2019-03-01FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for buspirone hydrochloride by Heritage Pharmaceuticals Inc. (d/b/a Avet Pharmaceuticals Inc.).
-
FDA approval · 2018-11-23FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Marlex Pharmaceuticals, Inc.)
FDA approved a generic venlafaxine hydrochloride product from Marlex Pharmaceuticals, marking the first original ANDA approval for this gene…
-
FDA approval · 2018-11-21FDA Approved: VENLAFAXINE — Original Application (Cadila Pharmaceuticals Limited)
FDA approved the original generic application for venlafaxine from Cadila Pharmaceuticals Limited.
-
FDA approval · 2018-07-19FDA Approved: DULOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental ANDA for a generic duloxetine product (ANDA204343). Duloxetine is indicated for major depr…
-
FDA approval · 2018-06-12FDA Approved: PAROXETINE — Original Application (Rhodes Pharmaceuticals L.P.)
FDA approved the original abbreviated new drug application for paroxetine hydrochloride hemihydrate from Rhodes Pharmaceuticals, establishin…
-
FDA approval · 2018-05-03FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (APNAR PHARMA LP)
The FDA approves an original ANDA for buspirone hydrochloride from APNAR PHARMA LP, enabling a generic version of buspirone to be marketed.
-
FDA approval · 2017-12-19FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.